Bell JC - Search Results

1

Bacterial-mediated knockdown of tumor resistance to an oncolytic virus enhances therapy.

Cronin M, Le Boeuf F, Murphy C, Roy DG, Falls T, Bell JC, Tangney M. Cronin M, et al. Among authors: bell jc. Mol Ther. 2014 Jun;22(6):1188-1197. doi: 10.1038/mt.2014.23. Epub 2014 Feb 26. Mol Ther. 2014. PMID: 24569832 Free PMC article.

2

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus.

Stojdl DF, Lichty B, Knowles S, Marius R, Atkins H, Sonenberg N, Bell JC. Stojdl DF, et al. Among authors: bell jc. Nat Med. 2000 Jul;6(7):821-5. doi: 10.1038/77558. Nat Med. 2000. PMID: 10888934

3

Oncolytic viruses: programmable tumour hunters.

Bell JC, Garson KA, Lichty BD, Stojdl DF. Bell JC, et al. Curr Gene Ther. 2002 May;2(2):243-54. doi: 10.2174/1566523024605582. Curr Gene Ther. 2002. PMID: 12109220 Review.

4

Getting oncolytic virus therapies off the ground.

Bell JC, Lichty B, Stojdl D. Bell JC, et al. Cancer Cell. 2003 Jul;4(1):7-11. doi: 10.1016/s1535-6108(03)00170-3. Cancer Cell. 2003. PMID: 12892708 Free article.

5

Vesicular stomatitis virus: re-inventing the bullet.

Lichty BD, Power AT, Stojdl DF, Bell JC. Lichty BD, et al. Among authors: bell jc. Trends Mol Med. 2004 May;10(5):210-6. doi: 10.1016/j.molmed.2004.03.003. Trends Mol Med. 2004. PMID: 15121047 Review.

6

Vesicular stomatitis virus: a potential therapeutic virus for the treatment of hematologic malignancy.

Lichty BD, Stojdl DF, Taylor RA, Miller L, Frenkel I, Atkins H, Bell JC. Lichty BD, et al. Among authors: bell jc. Hum Gene Ther. 2004 Sep;15(9):821-31. doi: 10.1089/hum.2004.15.821. Hum Gene Ther. 2004. PMID: 15353037

7

Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas.

Lun X, Yang W, Alain T, Shi ZQ, Muzik H, Barrett JW, McFadden G, Bell J, Hamilton MG, Senger DL, Forsyth PA. Lun X, et al. Cancer Res. 2005 Nov 1;65(21):9982-9990. doi: 10.1158/0008-5472.CAN-05-1201. Cancer Res. 2005. PMID: 16267023 Free PMC article.

8

Recent progress in the battle between oncolytic viruses and tumours.

Parato KA, Senger D, Forsyth PA, Bell JC. Parato KA, et al. Among authors: bell jc. Nat Rev Cancer. 2005 Dec;5(12):965-76. doi: 10.1038/nrc1750. Nat Rev Cancer. 2005. PMID: 16294217 Review.

9

Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress.

Blais JD, Addison CL, Edge R, Falls T, Zhao H, Wary K, Koumenis C, Harding HP, Ron D, Holcik M, Bell JC. Blais JD, et al. Among authors: bell jc. Mol Cell Biol. 2006 Dec;26(24):9517-32. doi: 10.1128/MCB.01145-06. Epub 2006 Oct 9. Mol Cell Biol. 2006. PMID: 17030613 Free PMC article.

10

Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity.

Power AT, Wang J, Falls TJ, Paterson JM, Parato KA, Lichty BD, Stojdl DF, Forsyth PA, Atkins H, Bell JC. Power AT, et al. Among authors: bell jc. Mol Ther. 2007 Jan;15(1):123-30. doi: 10.1038/sj.mt.6300039. Mol Ther. 2007. PMID: 17164783 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

376 results

Search Page

Filters